Since Notch‐1 is a vital element of the pathophysiology of human osteosarcoma and actively participates in the process of cell survival, invasiveness, and metastasizing, the use of this factor as a therapeutic target becomes highly interesting (Zhang et al. 2021). This evidence concerns the gene NOTCH1 and osteosarcoma.